Investors

Financials & Filings

Show all

2025

Q4

Q3

Q2

Q1

2024

Q4

Q3

Q2

Q1

2023

Q4

Q3

Q2

Q1

2022

Q4

Q3

Q2

Q1

2021

Q4

Q3

Q2

Q1

2020

Q4

Q3

Q2

Q1

2019

Q4

Q3

Q2

Q1

2018

Q4

Q3

Q2

Q1

2017

Q4

Q3

Q2

Q1

2016

Q4

Q3

Q2

Q1

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Request Information

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals

Sign Up